![1]()
News
ACE-I or ARB therapy in patients with low eGFR
August 26, 2021
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose estimated glomerular filtration rate (eGFR) has decreased to below 30 mL/min per 1.73 m2?
News
One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study
August 26, 2021
“We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”
![1]()
News
Efficacy of gabapentin for treatment of alcohol use disorders
August 25, 2021
Can gabapentin be used in the treatment of alcohol use disorder (AUD) to reduce heavy drinking and maintain abstinence?
News
New tool predicts pain relief after gallbladder surgery
August 25, 2021
“Until now, we did not know which patient with which symptoms would benefit most from this operation.”
![1]()
News
Children and COVID: New cases soar to near-record level
August 24, 2021
Vaccine initiations were down for the second consecutive week, but COVID-related deaths showed a big increase.
News
U.S. kidney transplants grow in number and success
August 24, 2021
Data from 1996 to 2019 show more U.S. kidney transplants recently than ever before, and steady improvements in graft and patient survival.
![1]()
News
CRP as a biomarker for community-acquired pneumonia
August 24, 2021
Can biomarkers such as C-reactive protine (CRP) or procalcitonin be used as tools in diagnosis of outpatient CAP (community-acquired pneumonia)?
News
Urologic surgery tied to persistent opioid usage, particularly with tramadol
August 23, 2021
“For me, the take-home message is that tramadol should not necessarily be considered less habit forming than other opioids, although further research is needed to substantiate this,” Dr. Sarah Faris said.
![1]()
News
SGLT2 inhibitor use rising in patients with DKD
August 23, 2021
Use of SGLT2 inhibitors in patients with type 2 diabetes rose sharply in 2019 and early 2020. GLP-1 RA use also showed recent gains.
![1]()
News
Apixaban more effective, safer than rivaroxaban for Afib patients
August 23, 2021
Is apixaban more effective and safer than rivaroxaban in patients with atrial fibrillation?
